The objective of the neuroimaging Core is to provide support for the clinical and neuropathology cores of the ADCC, for funded MR and PET projects and to promote new research opportunities. The core creates and maintains multiple databases across projects, imaging modalities, technical support functions and routine clinical needs. The neuroimaging core which has been in operation for one year has implemented a uniform and rapidly acquired high resolution MR protocol. In the pst year in collaboration with the clinical core over 200 MR studies were completed and normal aging MR data base was created. The core provides userfriendly procedures for reading, archiving, reformatting, region of interest work and maintaining the hardware environment. moreover, the new core has and is continuing to develop, test and implement several innovative and important anatomic tools. The ongoing work includes new MR sequences for tissue segmentation, multimodal coregistration of 3-D images sets, improved reformatting of high resolution MR data with stereotactic image marking, 3-D surface rendering and functional MR imaging. Many new clinical, neuropathology and technical projects have been initiated. A main research goal supported by the core has been to identify and validate in cognitively normal elderly, ante-mortem markers for AD. In recent years we have developed a line of investigation that has led to a predictive neuroimaging test for the development of AD. In the past year this work has resulted in the completion of several volumetric studies of normal aging and nondemented elderly at risk for the development of AD. These studies demonstrated within the temporal lobe, the existence of an anatomic specificity for hippocampal volume loss that is uniquely related to recent memory changes in both normal aging and in at risk patients. Current studies utilizing the core are now examining the specificity hypothesis across imaging modalities with respect ot other candidate brain regions. The core has continued its long established tradition of training new investigators and this is now extended to several other institutional settings. These collaborative efforts alone with the rich clinical environment of the ADCC provide access to different populations of patients and the sharing of new research strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG008051-09
Application #
6267420
Study Section
Project Start
1998-07-01
Project End
1999-04-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
New York University
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Herline, Krystal; Prelli, Frances; Mehta, Pankaj et al. (2018) Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Alzheimers Res Ther 10:54
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Goñi, Fernando; Martá-Ariza, Mitchell; Herline, Krystal et al. (2018) Anti-?-sheet conformation monoclonal antibody reduces tau and A? oligomer pathology in an Alzheimer's disease model. Alzheimers Res Ther 10:10
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 604 publications